SG159504A1 - Crystalline composition containing escitalopram oxalate - Google Patents
Crystalline composition containing escitalopram oxalateInfo
- Publication number
- SG159504A1 SG159504A1 SG201000567-6A SG2010005676A SG159504A1 SG 159504 A1 SG159504 A1 SG 159504A1 SG 2010005676 A SG2010005676 A SG 2010005676A SG 159504 A1 SG159504 A1 SG 159504A1
- Authority
- SG
- Singapore
- Prior art keywords
- escitalopram oxalate
- composition containing
- crystalline particles
- crystalline composition
- escitalopram
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400382 | 2004-03-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG159504A1 true SG159504A1 (en) | 2010-03-30 |
Family
ID=36607154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG201000567-6A SG159504A1 (en) | 2004-03-05 | 2005-02-21 | Crystalline composition containing escitalopram oxalate |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR20060126587A (zh) |
CN (3) | CN101492436A (zh) |
AR (1) | AR047749A1 (zh) |
IL (1) | IL177504A0 (zh) |
MY (1) | MY142756A (zh) |
PE (1) | PE20051162A1 (zh) |
SG (1) | SG159504A1 (zh) |
TW (1) | TW200605916A (zh) |
ZA (1) | ZA200607382B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114763343A (zh) * | 2021-01-14 | 2022-07-19 | 浙江华海药业股份有限公司 | 一种西酞普兰或s-西酞普兰的纯化方法 |
CN113663356B (zh) * | 2021-08-23 | 2022-09-23 | 广西埃索凯新材料科技有限公司 | 一种应用于硫酸锰生产的结晶除杂监控系统 |
-
2005
- 2005-02-17 TW TW094104639A patent/TW200605916A/zh unknown
- 2005-02-21 KR KR1020067017907A patent/KR20060126587A/ko not_active Application Discontinuation
- 2005-02-21 CN CNA2009100028561A patent/CN101492436A/zh active Pending
- 2005-02-21 ZA ZA200607382A patent/ZA200607382B/en unknown
- 2005-02-21 CN CNA2005800069400A patent/CN1925844A/zh active Pending
- 2005-02-21 SG SG201000567-6A patent/SG159504A1/en unknown
- 2005-02-21 CN CNA2009100028557A patent/CN101492435A/zh active Pending
- 2005-02-24 AR ARP050100683A patent/AR047749A1/es not_active Application Discontinuation
- 2005-03-02 PE PE2005000241A patent/PE20051162A1/es not_active Application Discontinuation
- 2005-03-03 MY MYPI20050870A patent/MY142756A/en unknown
-
2006
- 2006-08-15 IL IL177504A patent/IL177504A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR047749A1 (es) | 2006-02-15 |
CN1925844A (zh) | 2007-03-07 |
IL177504A0 (en) | 2006-12-10 |
CN101492436A (zh) | 2009-07-29 |
CN101492435A (zh) | 2009-07-29 |
ZA200607382B (en) | 2008-05-28 |
TW200605916A (en) | 2006-02-16 |
KR20060126587A (ko) | 2006-12-07 |
PE20051162A1 (es) | 2006-01-16 |
MY142756A (en) | 2010-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200519075A (en) | Novel compounds | |
BR0206164A (pt) | Partìculas cristalinas de oxalato de escitalopram, método para a produção de partìculas cristalinas de oxalato de escitalopram, e, forma de dosagem unitária sólida | |
WO2004014322A3 (en) | Immunomodulatory compositions, methods of making, and methods of use thereof | |
UA86595C2 (ru) | Гамма-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит | |
GEP20074030B (en) | Controlled synthesis of ziprasidone and compositions thereof | |
TW200510301A (en) | Novel compounds | |
MXPA04004956A (es) | Antagonistas de la hormona concentradora de melanina basados en la piperidina para tratamiento de la obesidad y de trastornos del sistema nervioso central. | |
MXPA04003858A (es) | Antagonistas de mch para el tratamiento de obesidad. | |
WO2011065800A3 (ko) | 피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물 | |
WO2006002140A3 (en) | Compositions comprising amphotericin b | |
CA2412161A1 (en) | Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones | |
WO2006124012A3 (en) | Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production | |
MY139902A (en) | Crystalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
WO2010131922A3 (en) | Amide compound, preparation method thereof and pharmaceutical composition comprising same | |
UA85041C2 (ru) | Способ лечения кишечной непроходимости | |
HK1102427A1 (en) | Compositions comprising strontium and vitamin d and uses thereof | |
UA103179C2 (ru) | Фармацевтическая композиция, которая содержит эзетимиб | |
IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
UA95088C2 (ru) | Композиция, которая содержит наночастички связанные с биосовместимым полимером противоракового агента и снижает аллопецию при химиотерапии, способ ее получения | |
HK1126194A1 (en) | Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same | |
MY137846A (en) | Processes for the preparation of oral dosage formulations of modafinil | |
WO2007087026A3 (en) | Solid-state form of amg 706 and pharmaceutical compositions thereof | |
EA200601641A1 (ru) | Кристаллическая композиция, содержащая оксалат эсциталопрама | |
SG159504A1 (en) | Crystalline composition containing escitalopram oxalate | |
AU2003251728A1 (en) | Placental growth factor as a target for the treatment of osteoporosis |